![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 31, 29200-29209, August 3, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cooperates with p21 to Inhibit
Cyclin-dependent Kinase-2 Activity and Induces Growth
Arrest Independent of DNA Binding*
§,
, and
From the CCAAT/enhancer-binding protein-
Cell and Molecular Biology Program and the
§ Roy M. and Phyllis Gough Huffington Center on Aging,
Baylor College of Medicine, Houston, Texas 77030, the ¶ Department
of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota
55415, and the
Department of Biochemistry, Nagoya City
University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku,
Nagoya 467-8601, Japan
(C/EBP
) is
a basic leucine zipper protein that controls transcription of genes
important for liver function, white adipose tissue development, and
granulocyte differentiation. In addition to its function in controlling
gene expression in differentiated tissues, C/EBP
is also associated with an antimitotic activity. We have previously demonstrated that C/EBP
interacts with p21, a cyclin-dependent kinase
(CDK) inhibitor, and that C/EBP
inhibits proliferation when
expressed in several different cell types (Timchenko, N. A., Harris, T. E., Wilde, M., Bilyeu, T. A., Burgess-Beusse, B. L., Finegold, M. J.,
and Darlington, G. J. (1997) Mol. Cell. Biol. 17, 7353-7361). Here we define the regions of C/EBP
required for
interaction with p21 and demonstrate that CDK2 also interacts with
C/EBP
. We show that C/EBP
can cooperate with p21 to inhibit CDK2
activity in vitro. The effect of C/EBP
on CDK2 activity
requires the p21 and CDK2 interaction sites within C/EBP
. C/EBP
mutants incapable of inhibiting CDK2 activity in vitro do
not inhibit proliferation in cultured cells. However, C/EBP
mutants
defective in DNA binding inhibit proliferation as effectively as the
wild-type protein. These findings show that C/EBP
-mediated growth
arrest occurs through protein interactions and is independent of its
transcriptional activity.
This article has been cited by other articles:
![]() |
S. Zhou, J. Si, T. Liu, and J. W. DeWille PIASy Represses CCAAT/Enhancer-binding Protein {delta} (C/EBP{delta}) Transcriptional Activity by Sequestering C/EBP{delta} to the Nuclear Periphery J. Biol. Chem., July 18, 2008; 283(29): 20137 - 20148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng, D. V. Yu, J.-H. Zhou, and D. J. Shapiro Tamoxifen Induction of CCAAT Enhancer-binding Protein {alpha} Is Required for Tamoxifen-induced Apoptosis J. Biol. Chem., October 19, 2007; 282(42): 30535 - 30543. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Loomis, S. Zhu, K. Yoon, P. F. Johnson, and R. C. Smart Genetic Ablation of CCAAT/Enhancer Binding Protein {alpha} in Epidermis Reveals Its Role in Suppression of Epithelial Tumorigenesis Cancer Res., July 15, 2007; 67(14): 6768 - 6776. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferrari-Amorotti, K. Keeshan, M. Zattoni, C. Guerzoni, G. Iotti, S. Cattelani, N. J. Donato, and B. Calabretta Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBP{alpha} Blood, August 15, 2006; 108(4): 1353 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, K. Miyake, H. Kaneoka, and S. Iijima Sumoylation of CCAAT/Enhancer-binding Protein {alpha} and Its Functional Roles in Hepatocyte Differentiation J. Biol. Chem., August 4, 2006; 281(31): 21629 - 21639. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakajima, N. Watanabe, F. Shibata, T. Kitamura, Y. Ikeda, and M. Handa N-terminal Region of CCAAT/Enhancer-binding Protein {epsilon} Is Critical for Cell Cycle Arrest, Apoptosis, and Functional Maturation during Myeloid Differentiation J. Biol. Chem., May 19, 2006; 281(20): 14494 - 14502. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yin and J. Glass In Prostate Cancer Cells the Interaction of C/EBP{alpha} with Ku70, Ku80, and Poly(ADP-ribose) Polymerase-1 Increases Sensitivity to DNA Damage J. Biol. Chem., April 28, 2006; 281(17): 11496 - 11505. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gustafson and U. Smith Cytokines Promote Wnt Signaling and Inflammation and Impair the Normal Differentiation and Lipid Accumulation in 3T3-L1 Preadipocytes J. Biol. Chem., April 7, 2006; 281(14): 9507 - 9516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, G. Liao, H. Chen, F. Y. Wu, L. Hutt-Fletcher, G. S. Hayward, and S. D. Hayward Contribution of C/EBP Proteins to Epstein-Barr Virus Lytic Gene Expression and Replication in Epithelial Cells J. Virol., February 1, 2006; 80(3): 1098 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di-Poi, B. Desvergne, L. Michalik, and W. Wahli Transcriptional Repression of Peroxisome Proliferator-activated Receptor {beta}/{delta} in Murine Keratinocytes by CCAAT/Enhancer-binding Proteins J. Biol. Chem., November 18, 2005; 280(46): 38700 - 38710. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, S. G. Carlson, D. McBurney, and W. E. Horton Jr. Multiple Signals Induce Endoplasmic Reticulum Stress in Both Primary and Immortalized Chondrocytes Resulting in Loss of Differentiation, Impaired Cell Growth, and Apoptosis J. Biol. Chem., September 2, 2005; 280(35): 31156 - 31165. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Johnson Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors J. Cell Sci., June 15, 2005; 118(12): 2545 - 2555. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-T. Chin, H.-J. Zhou, C.-M. Wong, J. M.-F. Lee, C.-P. Chan, B.-Q. Qiang, J.-G. Yuan, I. O.-l. Ng, and D.-Y. Jin The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma Nucleic Acids Res., March 30, 2005; 33(6): 1859 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fritah, C. Saucier, J. Mester, G. Redeuilh, and M. Sabbah p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor {alpha} Mol. Cell. Biol., March 15, 2005; 25(6): 2419 - 2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shim, K. L. Powers, S. J. Ewing, S. Zhu, and R. C. Smart Diminished Expression of C/EBP{alpha} in Skin Carcinomas Is Linked to Oncogenic Ras and Reexpression of C/EBP{alpha} in Carcinoma Cells Inhibits Proliferation Cancer Res., February 1, 2005; 65(3): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoon and R. C. Smart C/EBP{alpha} Is a DNA Damage-Inducible p53-Regulated Mediator of the G1 Checkpoint in Keratinocytes Mol. Cell. Biol., December 15, 2004; 24(24): 10650 - 10660. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. ZIESCHE, V. PETKOV, C. LAMBERS, P. ERNE, and L.-H. BLOCK The calcium channel blocker amlodipine exerts its anti-proliferative action via p21(Waf1/Cip1) gene activation FASEB J, October 1, 2004; 18(13): 1516 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schrem, J. Klempnauer, and J. Borlak Liver-Enriched Transcription Factors in Liver Function and Development. Part II: the C/EBPs and D Site-Binding Protein in Cell Cycle Control, Carcinogenesis, Circadian Gene Regulation, Liver Regeneration, Apoptosis, and Liver-Specific Gene Regulation Pharmacol. Rev., June 1, 2004; 56(2): 291 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C.K. Panguluri, L. O. Long, W. Chen, S. Wang, A. Coulibaly, F. Ukoli, A. Jackson, S. Weinrich, C. Ahaghotu, W. Isaacs, et al. COX-2 gene promoter haplotypes and prostate cancer risk Carcinogenesis, June 1, 2004; 25(6): 961 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Wu, S. E. Wang, H. Chen, L. Wang, S. D. Hayward, and G. S. Hayward CCAAT/Enhancer Binding Protein {alpha} Binds to the Epstein-Barr Virus (EBV) ZTA Protein through Oligomeric Interactions and Contributes to Cooperative Transcriptional Activation of the ZTA Promoter through Direct Binding to the ZII and ZIIIB Motifs during Induction of the EBV Lytic Cycle J. Virol., May 1, 2004; 78(9): 4847 - 4865. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Muller, C. F. Calkhoven, X. Sha, and A. Leutz The CCAAT Enhancer-binding Protein {alpha} (C/EBP{alpha}) Requires a SWI/SNF Complex for Proliferation Arrest J. Biol. Chem., February 20, 2004; 279(8): 7353 - 7358. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Ross, H. S. Radomska, B. Wu, P. Zhang, J. N. Winnay, L. Bajnok, W. S. Wright, F. Schaufele, D. G. Tenen, and O. A. MacDougald Phosphorylation of C/EBP{alpha} Inhibits Granulopoiesis Mol. Cell. Biol., January 15, 2004; 24(2): 675 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D'Alo', L. M. Johansen, E. A. Nelson, H. S. Radomska, E. K. Evans, P. Zhang, C. Nerlov, and D. G. Tenen The amino terminal and E2F interaction domains are critical for C/EBP{alpha}-mediated induction of granulopoietic development of hematopoietic cells Blood, November 1, 2003; 102(9): 3163 - 3171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ukomadu and A. Dutta p21-dependent Inhibition of Colon Cancer Cell Growth by Mevastatin Is Independent of Inhibition of G1 Cyclin-dependent Kinases J. Biol. Chem., October 31, 2003; 278(44): 43586 - 43594. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wang, F. Y. Wu, Y. Yu, and G. S. Hayward CCAAT/Enhancer-Binding Protein-{alpha} Is Induced during the Early Stages of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic Cycle Reactivation and Together with the KSHV Replication and Transcription Activator (RTA) Cooperatively Stimulates the Viral RTA, MTA, and PAN Promoters J. Virol., September 1, 2003; 77(17): 9590 - 9612. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Wu, S. E. Wang, Q.-Q. Tang, M. Fujimuro, C.-J. Chiou, Q. Zheng, H. Chen, S. D. Hayward, M. D. Lane, and G. S. Hayward Cell Cycle Arrest by Kaposi's Sarcoma-Associated Herpesvirus Replication-Associated Protein Is Mediated at both the Transcriptional and Posttranslational Levels by Binding to CCAAT/Enhancer-Binding Protein {alpha} and p21CIP-1 J. Virol., August 15, 2003; 77(16): 8893 - 8914. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Keeshan, G. Santilli, F. Corradini, D. Perrotti, and B. Calabretta Transcription activation function of C/EBP{alpha} is required for induction of granulocytic differentiation Blood, August 15, 2003; 102(4): 1267 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suzuki, A. Iwama, H. Miyashita, H. Nakauchi, and H. Taniguchi Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells Development, June 1, 2003; 130(11): 2513 - 2524. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schaufele, X. Wang, X. Liu, and R. N. Day Conformation of CCAAT/Enhancer-binding Protein alpha Dimers Varies with Intranuclear Location in Living Cells J. Biol. Chem., March 14, 2003; 278(12): 10578 - 10587. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Gigliotti, P. F. Johnson, E. Sterneck, and J. W. DeWille Nulliparous CCAAT/Enhancer Binding Protein{delta} (C/EBP{delta}) Knockout Mice Exhibit Mammary Gland Ductal Hyperlasia Experimental Biology and Medicine, March 1, 2003; 228(3): 278 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-T. H. Truong, Y.-J. Lee, T. A. Lodie, D. J. Park, D. Perrotti, N. Watanabe, H. P. Koeffler, H. Nakajima, D. G. Tenen, and S. C. Kogan CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia Blood, February 1, 2003; 101(3): 1141 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schuster, K. Forster, H. Dierks, A. Elsasser, G. Behre, N. Simon, S. Danhauser-Riedl, M. Hallek, and M. Warmuth The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate Blood, January 15, 2003; 101(2): 655 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Wu, H. Chen, S. E. Wang, C. M. J. apRhys, G. Liao, M. Fujimuro, C. J. Farrell, J. Huang, S. D. Hayward, and G. S. Hayward CCAAT/Enhancer Binding Protein {alpha} Interacts with ZTA and Mediates ZTA-Induced p21CIP-1 Accumulation and G1 Cell Cycle Arrest during the Epstein-Barr Virus Lytic Cycle J. Virol., December 20, 2002; 77(2): 1481 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wang, F. Y. Wu, M. Fujimuro, J. Zong, S. D. Hayward, and G. S. Hayward Role of CCAAT/Enhancer-Binding Protein Alpha (C/EBP{alpha}) in Activation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic-Cycle Replication-Associated Protein (RAP) Promoter in Cooperation with the KSHV Replication and Transcription Activator (RTA) and RAP J. Virol., December 6, 2002; 77(1): 600 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Wu, Q.-Q. Tang, H. Chen, C. ApRhys, C. Farrell, J. Chen, M. Fujimuro, M. D. Lane, and G. S. Hayward Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha PNAS, August 6, 2002; 99(16): 10683 - 10688. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-f. Wang and A. D. Friedman CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor Blood, April 15, 2002; 99(8): 2776 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Gombart, W.-K. Hofmann, S. Kawano, S. Takeuchi, U. Krug, S. H. Kwok, R. J. Larsen, H. Asou, C. W. Miller, D. Hoelzer, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias Blood, February 15, 2002; 99(4): 1332 - 1340. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |